PDB46 COST-UTILITY OF INSULIN DETEMIR VERSUS NPH FOR TYPE I DIABETES PATIENTS TREATED WITH BASAL-BOLUS THERAPY IN A FRENCH SETTING, A MODELING EVALUATION BASED ON RESULTS FROM A META-ANALYSIS OF THREE CLINICAL TRIALS
H Scheijbeler, M Aagren, S Nielsen, WJ Valentine, G Goodall, R KotchieVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64994-7
File:
PDF, 76 KB
english, 2007